Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Schmitt-Grohé

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Klinische Padiatrie|November 20, 2001
[Safety of an influenza-split-vaccine in children]S Schmitt-Grohé, A Banzhoff, B Klaassen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 1995
Pertussis in German adultsS Schmitt-Grohé, J D Cherry, U Heininger, et al.
Developments in Biological Standardization|January 1, 1997
Severe adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study GroupM A Uberall, K Stehr, J D Cherry, et al.
Developments in Biological Standardization|January 1, 1997
Minor adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study GroupS Schmitt-Grohé, K Stehr, J D Cherry, et al.
The Pediatric Infectious Disease Journal|March 1, 1995
Polymerase chain reaction identification of Bordetella pertussis infections in vaccinees and family members in a pertussis vaccine efficacy trial in GermanyG Schläpfer, J D Cherry, U Heininger, et al.
The Pediatric Infectious Disease Journal|April 1, 1994
Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussisU Heininger, K Stehr, S Schmitt-Grohé, et al.
Mediators of Inflammation|September 25, 2013
Transforming growth factor β1 genotypes in relation to TGFβ1, interleukin-8, and tumor necrosis factor alpha in induced sputum and blood in cystic fibrosisO Eickmeier, L v D Boom, F Schreiner, et al.
Pediatrics|September 17, 1998
Comparative Efficacy of the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine and Lederle whole-cell component DTP vaccine in German children after household exposure. Pertussis Vaccine Study GroupU Heininger, J D Cherry, K Stehr, et al.
Pediatrics|January 17, 1998
A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccineK Stehr, J D Cherry, U Heininger, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Klinische Padiatrie|November 20, 2001
[Safety of an influenza-split-vaccine in children]S Schmitt-Grohé, A Banzhoff, B Klaassen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 1995
Pertussis in German adultsS Schmitt-Grohé, J D Cherry, U Heininger, et al.
Developments in Biological Standardization|January 1, 1997
Severe adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study GroupM A Uberall, K Stehr, J D Cherry, et al.
Developments in Biological Standardization|January 1, 1997
Minor adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study GroupS Schmitt-Grohé, K Stehr, J D Cherry, et al.
The Pediatric Infectious Disease Journal|March 1, 1995
Polymerase chain reaction identification of Bordetella pertussis infections in vaccinees and family members in a pertussis vaccine efficacy trial in GermanyG Schläpfer, J D Cherry, U Heininger, et al.
The Pediatric Infectious Disease Journal|April 1, 1994
Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussisU Heininger, K Stehr, S Schmitt-Grohé, et al.
Mediators of Inflammation|September 25, 2013
Transforming growth factor β1 genotypes in relation to TGFβ1, interleukin-8, and tumor necrosis factor alpha in induced sputum and blood in cystic fibrosisO Eickmeier, L v D Boom, F Schreiner, et al.
Pediatrics|September 17, 1998
Comparative Efficacy of the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine and Lederle whole-cell component DTP vaccine in German children after household exposure. Pertussis Vaccine Study GroupU Heininger, J D Cherry, K Stehr, et al.
Pediatrics|January 17, 1998
A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccineK Stehr, J D Cherry, U Heininger, et al.
Pageof 1